Verrica Pharmaceuticals Inc.VRCANASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank78
3Y CAGR+15.5%
5Y CAGR+2.7%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+15.5%/yr
vs +7.9%/yr prior
5Y CAGR
+2.7%/yr
Recent acceleration
Acceleration
+7.6pp
Accelerating
Percentile
P78
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $45.57M | -35.6% |
| 2024 | $70.75M | +0.9% |
| 2023 | $70.14M | +136.9% |
| 2022 | $29.60M | -30.2% |
| 2021 | $42.44M | +6.2% |
| 2020 | $39.95M | +34.0% |
| 2019 | $29.82M | +36.3% |
| 2018 | $21.88M | +390.9% |
| 2017 | $4.46M | +133.0% |
| 2016 | $1.91M | - |